On July 21, 2025, Lixte Biotechnology announced the appointment of Jason Sawyer and Dr. Michael Holloway to its Board of Directors, after the resignation of Dr. Stephen Forman and Dr. Yun Yen, who are now part of the Scientific Advisory Committee. Additionally, Dr. Jan Schellens, Chief Medical Officer, will resign effective July 31, 2025, for other opportunities, with no disagreements reported.